Team, Inc. (TISI)
Live price chart, market sentiment, and community perspectives for Team, Inc. (NYSE: TISI).
Live price chart, market sentiment, and community perspectives for Team, Inc. (NYSE: TISI).
On our equity desk, the big headline from the Q2 2026 print isn't just the softer top-line numbers—it's Stellex Capital Management stepping in to acquire Corre Partners' entire stake, making them the undisputed largest common equity holder. That kind of concentrated backing signals long-term conviction despite the near-term noise. We are advising clients to look past the temporary deferral of turnaround projects and focus on how this ownership consolidation aligns with their ongoing internal transformation.
As a quantitative analyst modeling industrial service providers, I note that TISI's full-year 2026 guidance was reaffirmed, though management explicitly flagged that results will land at the lower end of the range. The compression in gross margins down to $54.4 million shows that labor utilization in Mechanical Services took a real hit. Anyone building valuation models needs to discount near-term cash flows while baking in the structural cost reduction targets recently announced.
Watching the mechanics of TISI's Q2 earnings, the revenue drop to $228.7 million from $248.0 million and the wider net loss of $6.8 million are clearly tied to macro factors. High crack spreads and Middle East geopolitical tensions drove refineries to keep running rather than shut down for routine maintenance. While this hurts current-period service demand, it creates a massive pent-up backlog for mechanical and inspection services down the road.
On our options desk, TISI's implied volatility reflects the earnings digestion period following the August disclosures. With the stock trading around $22.36 and a 52-week range stretching from $12.34 to $23.48, participants are pricing in the reality that Q2 results missed prior run rates. However, with Stellex locking in its position as the dominant equity holder, speculative downside looks increasingly cushioned by strategic sponsorship.
From a risk management perspective, TISI's beta sits right around 1.09, but the single-day volume and market cap of roughly $102M mean liquidity can dry up quickly. The shareholder shift involving Stellex provides a solid governance floor, but short-term volatility will persist as long as customers continue deferring turnaround activities to capitalize on favorable refining economics.
Explore plasma cleansing, somatic organ swaps, and BCI.